Diab

Description

Gliclazide is an oral hypoglycemic (anti-diabetic drug) and is classified as a sulfonylurea.

Indications

Gliclazide is indicated in patients with type 2 diabetes when diet and exercise do not result in adequate glycemic control.

Subject to medical prescription

Pharmaceutical form: 80 mg x 60 film-coated tablets

NHIF code: AF317          ICD: E11.2, E11.3, E11.4, E11.5, E11.9

diab_bg_80mg